SGHT Sight Sciences, Inc. NASDAQ · United States

Sight Sciences (SGHT) news

Sight Sciences, Inc. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker SGHT, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Sight Sciences news

We have not published a story on Sight Sciences yet. When there is news, it will appear here.

Sight Sciences annual financials

Line	FY2025	FY2024
Revenue	$77.4 million	$79.9 million
Research and development	$14.6 million	$18.0 million
Net income (loss)	-$38.4 million	-$51.5 million
Cash from operations	-$29.7 million	-$22.4 million
Cash and equivalents	$92.0 million	$120.4 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $79.8 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Sight Sciences

What is the ticker symbol of Sight Sciences?

Sight Sciences, Inc. trades under the ticker SGHT on NASDAQ.

Where is Sight Sciences listed?

Sight Sciences, Inc. is listed on NASDAQ.

Which country or territory is Sight Sciences listed under?

Our directory records Sight Sciences, Inc. under United States.

Does aibio.space cover Sight Sciences?

aibio.space lists Sight Sciences, Inc. among 2,820 public biotech companies and publishes its news here as stories appear.

What was Sight Sciences's revenue last year?

$77.4 million for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Sight Sciences profitable?

Sight Sciences, Inc. reported a net loss of $38.4 million for the fiscal year ended Dec 31, 2025, and used $29.7 million of cash in operations, per its annual report to the SEC.

How much does Sight Sciences spend on research and development?

$14.6 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Sight Sciences have?

$79.8 million in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: Sight Sciences

Members talk about Sight Sciences (SGHT). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NASDAQ:SGHT on TradingView.

Listing details

Company: Sight Sciences, Inc.
Ticker: SGHT
Listing: NASDAQ
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction